Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Rank	Δ	Cancer	Trial Gap Index (percentile points)	Percentile	Confidence	Sources	Why #n?
1	=	Malignant Colon Neoplasm	+55.6	100	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 20751 formula percentile(mortality_count) − percentile(active_trials) activity 225 burdenPercentile 92.6 activityPercentile 37 ranking row 2598238
2	=	Malignant Vulvar Neoplasm	+22.2	96.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 942 formula percentile(mortality_count) − percentile(active_trials) activity 54 burdenPercentile 29.6 activityPercentile 7.4 ranking row 2598239
3	=	Cutaneous Melanoma	+18.5	92.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3152 formula percentile(mortality_count) − percentile(active_trials) activity 78 burdenPercentile 40.7 activityPercentile 22.2 ranking row 2598240
4	=	Malignant Ovarian Neoplasm	+14.8	88.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 14572 formula percentile(mortality_count) − percentile(active_trials) activity 684 burdenPercentile 85.2 activityPercentile 70.4 ranking row 2598241
5	=	Malignant Bladder Neoplasm	+11.2	85.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4302 formula percentile(mortality_count) − percentile(active_trials) activity 346 burdenPercentile 55.6 activityPercentile 44.4 ranking row 2598242
6	=	Malignant Vaginal Neoplasm	+11.1	81.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 423 formula percentile(mortality_count) − percentile(active_trials) activity 31 burdenPercentile 11.1 activityPercentile 0 ranking row 2598243
7	=	Malignant Laryngeal Neoplasm	+11.1	77.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 740 formula percentile(mortality_count) − percentile(active_trials) activity 66 burdenPercentile 25.9 activityPercentile 14.8 ranking row 2598244
8	=	Malignant Pancreatic Neoplasm	+7.4	74.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 18189 formula percentile(mortality_count) − percentile(active_trials) activity 904 burdenPercentile 88.9 activityPercentile 81.5 ranking row 2598245
9	=	Malignant Kidney Neoplasm	+7.4	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4783 formula percentile(mortality_count) − percentile(active_trials) activity 453 burdenPercentile 63 activityPercentile 55.6 ranking row 2598246
10	=	Malignant Rectal Neoplasm	+3.8	66.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4221 formula percentile(mortality_count) − percentile(active_trials) activity 386 burdenPercentile 51.9 activityPercentile 48.1 ranking row 2598247
11	=	Malignant Thyroid Gland Neoplasm	+3.7	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 963 formula percentile(mortality_count) − percentile(active_trials) activity 176 burdenPercentile 33.3 activityPercentile 29.6 ranking row 2598248
12	=	Malignant Breast Neoplasm	0	59.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 40996 formula percentile(mortality_count) − percentile(active_trials) activity 2627 burdenPercentile 96.3 activityPercentile 96.3 ranking row 2598249
12	=	Malignant Lung Neoplasm	0	59.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 70550 formula percentile(mortality_count) − percentile(active_trials) activity 2644 burdenPercentile 100 activityPercentile 100 ranking row 2598250
14	=	Malignant Anal Neoplasm	-3.7	51.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 478 formula percentile(mortality_count) − percentile(active_trials) activity 68 burdenPercentile 14.8 activityPercentile 18.5 ranking row 2598253
14	=	Malignant Mesothelioma	-3.7	51.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 530 formula percentile(mortality_count) − percentile(active_trials) activity 96 burdenPercentile 22.2 activityPercentile 25.9 ranking row 2598251
14	=	Malignant Salivary Gland Neoplasm	-3.7	51.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 286 formula percentile(mortality_count) − percentile(active_trials) activity 63 burdenPercentile 7.4 activityPercentile 11.1 ranking row 2598252
17	=	Malignant Hypopharyngeal Neoplasm	-3.7	40.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 71 formula percentile(mortality_count) − percentile(active_trials) activity 53 burdenPercentile 0 activityPercentile 3.7 ranking row 2598254
18	=	Malignant Central Nervous System Neoplasm	-7.4	37	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 6187 formula percentile(mortality_count) − percentile(active_trials) activity 823 burdenPercentile 70.4 activityPercentile 77.8 ranking row 2598255
18	=	Multiple Myeloma	-7.4	37	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5141 formula percentile(mortality_count) − percentile(active_trials) activity 814 burdenPercentile 66.7 activityPercentile 74.1 ranking row 2598256
20	=	Leukemia	-7.4	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9761 formula percentile(mortality_count) − percentile(active_trials) activity 1769 burdenPercentile 81.5 activityPercentile 88.9 ranking row 2598257
20	=	Malignant Gastric Neoplasm	-7.4	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4687 formula percentile(mortality_count) − percentile(active_trials) activity 652 burdenPercentile 59.3 activityPercentile 66.7 ranking row 2598258
22	=	Malignant Uterine Corpus Neoplasm	-7.5	22.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3644 formula percentile(mortality_count) − percentile(active_trials) activity 411 burdenPercentile 44.4 activityPercentile 51.9 ranking row 2598259
23	=	Malignant Liver Neoplasm	-11.1	18.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 6647 formula percentile(mortality_count) − percentile(active_trials) activity 906 burdenPercentile 74.1 activityPercentile 85.2 ranking row 2598260
24	=	Malignant Cervical Neoplasm	-11.2	14.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3939 formula percentile(mortality_count) − percentile(active_trials) activity 505 burdenPercentile 48.1 activityPercentile 59.3 ranking row 2598261
25	=	Hodgkin Lymphoma	-14.8	11.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 517 formula percentile(mortality_count) − percentile(active_trials) activity 179 burdenPercentile 18.5 activityPercentile 33.3 ranking row 2598262
25	=	Non-Hodgkin Lymphoma	-14.8	11.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9247 formula percentile(mortality_count) − percentile(active_trials) activity 2168 burdenPercentile 77.8 activityPercentile 92.6 ranking row 2598263
27	=	Malignant Esophageal Neoplasm	-26	3.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3074 formula percentile(mortality_count) − percentile(active_trials) activity 518 burdenPercentile 37 activityPercentile 63 ranking row 2598264
28	=	Malignant Nasopharyngeal Neoplasm	-37	0	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 222 formula percentile(mortality_count) − percentile(active_trials) activity 261 burdenPercentile 3.7 activityPercentile 40.7 ranking row 2598265

Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash 7f8158596bbd1efe63783497

Methodology

How this table was built

Formula: percentile(mortality_count) − percentile(active_trials)
Version: ci-trial-gap-v1
Scope: USA · Female · all ages · 2010 · top-level cancers
Scope key: geo=USA|sex=female|age=all|year=2010|level=top
Eligible entities: 28
Generated: Sep 29, 2026, 06:30 AM UTC
Inputs hash: 7f8158596bbd1efe63783497
Sources: U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality clinicaltrials cdc-wonder seer iarc-globocan
Aggregation: none

Eligibility

requires: mortality_count
active_trials
entityLevel: top

Full methodology · ties share a rank (1, 2, 2, 4) · previous rank refers to the last snapshot of the same scope.

Download CSV (with attribution)

Burden and lethality metrics depend on registry definitions (site groups, standard population, estimate type). Compare only within one table.